Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on October 18, 2024

Solventum Stock Earns 81 RS Rating

Investor's Business Daily

2 days ago

Solventum Stock Earns 81 RS Rating

MT Newswires

3 days ago

Leerink Adjusts Price Target on Insulet to $262 From $240

Insulet price target raised to $260 from $250 at BTIG

TipRanks

3 days ago

Insulet price target raised to $260 from $250 at BTIG

MT Newswires

3 days ago

BTIG Adjusts Price Target on Insulet to $260 From $250

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

6 days ago

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

Simply Wall St.

7 days ago

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

National Campaign Launches to Combat Diabetes Stigma Using Comedy

PR Newswire

8 days ago

National Campaign Launches to Combat Diabetes Stigma Using Comedy

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

GuruFocus.com

8 days ago

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

MT Newswires

8 days ago

Baird Adjusts Price Target on Insulet to $280 From $238, Maintains Outperform Rating

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)

Insider Monkey

9 days ago

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)

Argus Research

9 days ago

PODD: Lowering target price to $185.00

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition

GuruFocus.com

10 days ago

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition

HLN or PODD: Which Is the Better Value Stock Right Now?

Zacks

14 days ago

HLN or PODD: Which Is the Better Value Stock Right Now?

MT Newswires

17 days ago

Citigroup Adjusts Price Target on Insulet to $275 From $250, Maintains Buy Rating

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size

Insider Monkey

17 days ago

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Business Wire

18 days ago

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years

Simply Wall St.

21 days ago

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years

MT Newswires

23 days ago

Canaccord Genuity Adjusts Insulet Price Target to $269 From $236, Maintains Buy Rating

MT Newswires

a month ago

Piper Sandler Adjusts Price Target on Insulet to $285 From $230, Maintains Overweight Rating

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

Zacks

a month ago

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Simply Wall St.

a month ago

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $1,718,283, According to a Recent SEC Filing

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)

GuruFocus.com

a month ago

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $1,129,200, According to a Recent SEC Filing

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Insider Monkey

a month ago

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Morningstar Research

a month ago

Analyst Report: Insulet Corporation

Should You Continue to Retain PODD Stock in Your Portfolio Now?

Zacks

a month ago

Should You Continue to Retain PODD Stock in Your Portfolio Now?

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Simply Wall St.

2 months ago

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Why Insulet Stock Was Zooming Higher This Week

Motley Fool

2 months ago

Why Insulet Stock Was Zooming Higher This Week

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares

GuruFocus.com

2 months ago

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares

Argus Research

2 months ago

PODD: Raising target price to $202.00

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

Investopedia

2 months ago

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher in Late Afternoon

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More

Investopedia

2 months ago

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval

Barrons.com

2 months ago

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes

Zacks

2 months ago

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

MedTech Dive

2 months ago

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

Insulet Omnipod cleared by FDA for type 2 diabetes

Medical Device Network

2 months ago

Insulet Omnipod cleared by FDA for type 2 diabetes

MT Newswires

2 months ago

Insulet Receives US FDA Clearance for Omnipod 5 in Adults with Type 2 Diabetes

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

Business Wire

2 months ago

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

Insulet expands Omnipod 5 pump to people with Type 2 diabetes

MedTech Dive

2 months ago

Insulet expands Omnipod 5 pump to people with Type 2 diabetes

Argus Research

2 months ago

PODD: Raising target price to $192.00

These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise

Investopedia

2 months ago

These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise

Insulet to Present at Upcoming Investor Conferences

Business Wire

2 months ago

Insulet to Present at Upcoming Investor Conferences

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now

Insider Monkey

2 months ago

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now

Insulet (NASDAQ:PODD) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Simply Wall St.

2 months ago

Insulet (NASDAQ:PODD) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

MT Newswires

2 months ago

Insulet Opens New Manufacturing Facility in Malaysia

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

Business Wire

2 months ago

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

Insulet Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

2 months ago

Insulet Second Quarter 2024 Earnings: Beats Expectations

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

GuruFocus.com

2 months ago

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat

Investopedia

2 months ago

S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat

Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Investopedia

2 months ago

Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Here’s Why.

Barrons.com

2 months ago

Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Here’s Why.

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst

Benzinga

2 months ago

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst

MT Newswires

2 months ago

UBS Adjusts Insulet Price Target to $223 From $211, Maintains Neutral Rating

Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised

Zacks

2 months ago

Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised

MT Newswires

2 months ago

Canaccord Genuity Adjusts Price Target on Insulet to $236 From $234

MT Newswires

2 months ago

Wolfe Research Adjusts Price Target on Insulet to $220 From $205

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Insulet to $250 From $225

MT Newswires

2 months ago

BTIG Adjusts Price Target on Insulet to $250 From $270

MT Newswires

2 months ago

Barclays Adjusts Price Target on Insulet to $220 From $200

Reuters

2 months ago

Insulet inventory pressures cloud annual revenue forecast raise

Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks

2 months ago

Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say

Insulet (PODD) Q2 Earnings Miss Estimates

Zacks

2 months ago

Insulet (PODD) Q2 Earnings Miss Estimates

MT Newswires

2 months ago

Insulet Q2 Adjusted Earnings, Revenue Rise

Associated Press Finance

2 months ago

Insulet: Q2 Earnings Snapshot

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

Business Wire

2 months ago

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

Earnings To Watch: Insulet Corp (PODD) Reports Q2 2024 Result

GuruFocus.com

2 months ago

Earnings To Watch: Insulet Corp (PODD) Reports Q2 2024 Result

Unlocking Q2 Potential of Insulet (PODD): Exploring Wall Street Estimates for Key Metrics

Zacks

2 months ago

Unlocking Q2 Potential of Insulet (PODD): Exploring Wall Street Estimates for Key Metrics

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Is It Time To Consider Buying Insulet Corporation (NASDAQ:PODD)?

Simply Wall St.

3 months ago

Is It Time To Consider Buying Insulet Corporation (NASDAQ:PODD)?

EYE vs. PODD: Which Stock Is the Better Value Option?

Zacks

3 months ago

EYE vs. PODD: Which Stock Is the Better Value Option?

MT Newswires

3 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $240 From $235

Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?

The Wall Street Journal

3 months ago

Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?

MT Newswires

3 months ago

Insulet Shares Rise Pre-Bell After Company Posts Higher Preliminary Q2 Revenue

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

Business Wire

3 months ago

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy

Zacks

3 months ago

All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy

Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?

Simply Wall St.

3 months ago

Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Business Wire

3 months ago

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2

Barrons.com

4 months ago

Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Zacks

4 months ago

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

Bloomberg

4 months ago

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes

Zacks

4 months ago

Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes

Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

MedTech Dive

4 months ago

Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

Insulet plans label expansion for Omnipod in type 2 diabetes

Medical Device Network

4 months ago

Insulet plans label expansion for Omnipod in type 2 diabetes

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Business Wire

4 months ago

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Insulet (PODD) Faces Increasing Competition

Insider Monkey

4 months ago

Insulet (PODD) Faces Increasing Competition

Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

Zacks

4 months ago

Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

MT Newswires

4 months ago

Insulet Launches Omnipod 5 Tubeless Insulin System in the UK, Netherlands

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Business Wire

4 months ago

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Business Wire

4 months ago

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

GuruFocus.com

4 months ago

Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

MT Newswires

4 months ago

Insulet Insider Sold Shares Worth $299,940, According to a Recent SEC Filing

Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?

Zacks

4 months ago

Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 06/12/2024

Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)

GuruFocus.com

4 months ago

Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)

Share on Social Networks: